Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
UBS
Queensland Health
US Department of Justice
Fish and Richardson
Boehringer Ingelheim
Cantor Fitzgerald
AstraZeneca
Federal Trade Commission

Generated: April 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: risedronate sodium

« Back to Dashboard

risedronate sodium

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Apil ATELVIA risedronate sodium TABLET, DELAYED RELEASE;ORAL 022560 NDA Allergan, Inc. N 0430-0979-03
Apil ATELVIA risedronate sodium TABLET, DELAYED RELEASE;ORAL 022560 NDA Actavis Pharma, Inc. N 0591-3876-04
Apil ATELVIA risedronate sodium TABLET, DELAYED RELEASE;ORAL 022560 NDA Greenstone LLC N 59762-0407-4
Teva Pharms Usa RISEDRONATE SODIUM risedronate sodium TABLET, DELAYED RELEASE;ORAL 203217 ANDA Teva Pharmaceuticals USA Inc N 0093-5509-44
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Argus Health
Citi
Moodys
Harvard Business School
Cantor Fitzgerald
Merck
AstraZeneca